Eli Lilly is heading into 2023 with momentum. CEO Dave Ricks joins us with a look at what some say could be an “unprecedented year” and plans for major investment at the LEAP Innovation & Research District in Lebanon.

{{ articles_remaining }}
Free {{ article_text }} Remaining
{{ articles_remaining }}
Free {{ article_text }} Remaining Article limit resets on
{{ count_down }}